CVE-2026-73312XenForo < 2.3.13 Refresh Token Replay via Expired Access Token
Updated under an hour ago ()
Does this affect you?
It affects XenForo. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
XenForo before 2.3.13 contains a refresh token replay vulnerability that allows attackers to reuse a refresh token multiple times by exploiting the failure to mark tokens as consumed when the parent access token has expired. Attackers can repeatedly submit the same refresh token to generate additional independent token pairs, achieving persistent unauthorized access for the token's full lifetime.
- CVSS
- 7.4 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N
- Weakness (CWE)
- CWE-294
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- VulnCheck
- NVD analysis
- Analyzed
- Record last updated
- Oct 1, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
XenForo XenForo xenforo:xenforo (from the name) | before 2.3.13 | CNA record |
xenforo xenforo xenforo:xenforo | before 2.3.13 | NVD |
References
- https://xenforo.com/community/threads/security-fixes-released-for-all-xenforo-and-media-gallery-versions-2-2-0-2-3-12.239856/vendor-advisory, patch, release-notes
- https://xenforo.com/community/threads/xenforo-2-3-13-and-add-ons-released-includes-security-fixes.239857/release-notes
- https://bombobombone.github.io/posts/cve-2026-73312/technical-description, exploit, third-party-advisory
- https://github.com/BomboBombone/CVE-2026-73312exploit, third-party-advisory
- https://www.vulncheck.com/advisories/xenforo-refresh-token-replay-via-expired-access-tokenthird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.